In vitro antibacterial and antimalarial activity of dehydrophenylalanine- containing undecapeptides alone and in combination with drugs

International Journal of Antimicrobial Agents

Volumn 39, Issue 2, 2012, Pages 146-152

  Sharma, Sarika Pathak ^a   Sharma, Jyotsna ^a,c   Kanwar, Shamsher Singh ^b   Chauhan, Virander Singh ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b HIMACHAL PRADESH UNIVERSITY   (India)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Antimicrobial peptides; Antiplasmodial activity; De novo design; Dehydrophenylalanine

Indexed keywords

ALANINE; AMINO ACID; CHLOROQUINE; DEHYDROPHENYLALANINE; KANAMYCIN; PEPTIDE DERIVATIVE; RIFAMPICIN; TRYPTOPHAN; UNCLASSIFIED DRUG; UNDECAPEPTIDE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG PROTEIN BINDING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PROBE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIMALARIALS; ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; DRUG INTERACTIONS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENYLALANINE; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855500223     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.10.008     Document Type: Article

References (30)

1. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004;10(12 Suppl.):S122-9. (Pubitemid 40018235)
2. Rybak MJ, McGrath BJ. Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician. Drugs 1996;52:390-405. (Pubitemid 26293863)
3. Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 2001;1:156-64. (Pubitemid 33586049)
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95. (Pubitemid 34100944)
5. Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005;62:784-90. (Pubitemid 40655628)
6. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005;62:2588-98. (Pubitemid 41721232)
7. Pacor S, Giangaspero A, Bacac M, Sava G, Tossi A. Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. J Antimicrob Chemother 2002;50:339-48.
8. Rathinakumar R, Wimley WC. Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc 2008;130:9849-58.
9. Tew GN, Liu D, Chen B, Doerksen RJ, Kaplan J, Carroll PJ, et al. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA 2002;99:5110-4. (Pubitemid 34411511)
10. Pathak S, Chauhan VS. Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency. Antimicrob Agents Chemother 2011;55:2178-88.
11. Meyer WL, Kuyper LF, Lewis RB, Templeton GE, Woodhead SH. The amino acid sequence and configuration of tentoxin. Biochem Biophys Res Commun 1974;56:234-40.
12. Mathur P, Ramakumar S, Chauhan VS. Peptide design using α,β-dehydro amino acids: from β-turns to helical hairpins. Biopolymers 2004;76:150-61. (Pubitemid 38529430)
13. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 1970;34:595-8.
14. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 2004;48:1803-6. (Pubitemid 38544392)
15. Mathur P, Jagannathan NR, Chauhan VS. α,β-Dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity. J Pept Sci 2007;13:253-62. (Pubitemid 46638196)
16. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg 2008;102:346-51.
17. Giangaspero A, Sandri L, Tossi A. Amphipathic α helical antimicrobial peptides. Eur J Biochem 2001;268:5589-600.
18. Tossi A, Tarantino C, Romeo D. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem 1997;250:549-58. (Pubitemid 28012699)
19. Ghosh JK, Shaool D, Guillaud P, Ciceron L, Mazier D, Kustanovich I, et al. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J Biol Chem 1997;272:31609-16. (Pubitemid 28013305)
20. Zelezetsky I, Pacor S, Pag U, Papo N, Shai Y, Sahl HG, et al. Controlled alteration of the shape and conformational stability of α-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem J 2005;390:177-88. (Pubitemid 41192243)
21. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem Cell Biol 2002;80:667-77. (Pubitemid 36124825)
22. Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 1992;267:4292-5.
23. Blondelle SE, Simpkins LR, Pérez-Payá E, Houghten RA. Influence of tryptophan residues on melittin's hemolytic activity. Biochim Biophys Acta 1993;1202:331-6. (Pubitemid 23295747)
24. Liu LP, Li SC, Goto NK, Deber CM. Threshold hydrophobicity dictates helical conformations of peptides in membrane environments. Biopolymers 1996;39:465-70.
25. Hwang PM, Vogel HJ. Structure-function relationships of antimicrobial peptides. Biochem Cell Biol 1998;76:235-46. (Pubitemid 29102008)
26. Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Mocchegiani F, et al. Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. J Antimicrob Chemother 2008;62:1332-8.
27. Minahk CJ, Dupuy F, Morero RD. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J Antimicrob Chemother 2004;53:240-6. (Pubitemid 38239956)
28. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002;2:209-18. (Pubitemid 34464751)
29. Gwadz RW, Kaslow D, Lee JY, Maloy WL, Zasloff M, Miller LH. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect Immun 1989;57:2628-33. (Pubitemid 19212590)
30. Gelhaus C, Jacobs T, Andra J, Leippe M. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum. Antimicrob Agents Chemother 2008;52:1713-20. (Pubitemid 351614664)